Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6468665

CCOc1cccc2c(O)nc(Nc3nc(C)c4cc(OC)c(OC)cc4n3)nc12.O=C(O)C(F)(F)F

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.40
TP53 P04637 2/20 0.40
MAPT P10636 2/20 0.40
MEN1 O00255 1/20 0.40
ABCG2 Q9UNQ0 1/20 0.38
WHR1 P49842 2/20 0.38
AURKA O14965 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
ADORA2B P29275 1/20 0.37
PDE10A Q9Y233 2/20 0.37
DPP4 P27487 1/20 0.37
EHMT2 Q96KQ7 1/20 0.37
CTSG P08311 1/20 0.36
KLK7 P49862 1/20 0.36
KLK14 Q9P0G3 1/20 0.36
KLK5 Q9Y337 1/20 0.36
POLB P06746 1/20 0.36
GAA P10253 1/20 0.36
PDE5A O76074 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6467464 0.92 ADORA2B (0.43) KMT2ATP53MAPTMEN1ABCG2
Trifluoroacetic Acid SCHEMBL6468655 0.88 FGFR1 (0.39) KMT2ASMN1; SMN2
Trifluoroacetic Acid SCHEMBL6467189 0.88 ABCG2 (0.41) KMT2ATP53MAPTMEN1ABCG2
Trifluoroacetic Acid SCHEMBL6467171 0.88 KMT2A (0.40) KMT2ATP53MAPTMEN1ABCG2
Trifluoroacetic Acid SCHEMBL6466274 0.87 KMT2A (0.39) KMT2ATP53MAPTMEN1ABCG2
Trifluoroacetic Acid SCHEMBL6468597 0.86 KMT2A (0.39) KMT2ATP53MAPTMEN1ABCG2
SCHEMBL6468667 0.85 TP53 (0.40) KMT2ATP53MAPTMEN1ABCG2
SCHEMBL6467174 0.85 ABCG2 (0.40) KMT2ATP53MAPTMEN1ABCG2
Trifluoroacetic Acid SCHEMBL6469860 0.84 KMT2A (0.38) KMT2AMAPTABCG2WHR1SMN1; SMN2
Trifluoroacetic Acid SCHEMBL6466277 0.83 ABCG2 (0.40) KMT2ATP53MAPTMEN1ABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections REPLIDYNE, INC. 2005-06-09 US claimed
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections REPLIDYNE, INC. 2005-06-09 US disclosed
WO-2005030131-A2 BIS-QUINAZOLINE COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS REPLIDYNE, INC (US) 2005-04-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections POLI, POLK, POLB KMT2A 2156/4885TP53 1339/4885MAPT 3552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.